Mapping lung cancer genes to unlock future treatments
NCT ID NCT02688894
First seen Jun 24, 2026 · Last updated Jun 24, 2026
Summary
This study analyzes tumor tissue from 797 people with relapsed small cell lung cancer to identify genetic subtypes. No drugs are tested here. Instead, the results may help match patients to future targeted therapy trials. Participants must have had prior platinum-based chemotherapy and provide tissue samples.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NEUROENDOCRINE CARCINOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Chungbuk University Hospital
COMPLETEDTaebuk, South Korea
-
Gachon University Gil Medical Center
COMPLETEDIncheon, South Korea
-
Samsung Medical Center
RECRUITINGSeoul, 135-710, South Korea
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Seoul National University Bundang Hospital
COMPLETEDSeongnam, South Korea
-
Ulsan University Hospital
COMPLETEDUlsan, South Korea
-
VHS Medical Center
COMPLETEDSeoul, South Korea
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this screening could identify which genetic subtypes of small cell lung cancer exist, paving the way for more personalized treatment trials.
What could go wrong
This is only a screening study, not a treatment. It does not test any drug, so there is no direct benefit to participants. Results may not lead to effective therapies.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.